3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Vulvar Diseases
1
Papillomavirus Infections
1
Interventions
Specimen Handling
7
Human Papillomavirus Recombinant Vaccine nonavalent
6
Radiotherapy, Intensity-Modulated
5
Human Papillomavirus DNA Tests
5
Colposcopy
5
Cisplatin
5
Patient Navigation
3
Methods
3
Early Intervention, Educational
3
Carboplatin
3
human papillomavirus vaccine, L1 type 16, 18
2
epigallocatechin gallate
2
artesunic acid
2
artemisinin
2
Standard of Care
2
Practice Guidelines as Topic
2
Papillomavirus Vaccines
2
Mass Screening
2
Educational Status
2
Docetaxel
2
Cytological Techniques
2
Blood Specimen Collection
2
Biopsy
2
toripalimab
1
fludarabine phosphate
1
fludarabine
1
artenimol
1
aldesleukin
1
adacel
1
Watchful Waiting
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Papillomavirus Infections
×
artenimol
×
1 year
×
Clear all
NCT06075264
2025-08-14
ART-VIN IIB
Frantz Viral Therapeutics, LLC
Phase 2
Recruiting
27 enrolled